Arzneibuch der Vereinigten Staaten von Amerika (USP) Lösungen und Reagenzien
Lösungen und Reagenzien der United States Pharmacopeia (USP) sind entscheidend für die Sicherstellung der Sicherheit, Qualität und Wirksamkeit von Arzneimitteln auf dem US-Markt. Diese Produkte entsprechen den von der USP festgelegten Standards und werden häufig in der Arzneimittelentwicklung und Qualitätskontrolle eingesetzt. Bei CymitQuimica bieten wir eine umfassende Auswahl an USP-konformen Lösungen und Reagenzien zur Unterstützung der pharmazeutischen Forschung und Herstellung an.
Unterkategorien von "Arzneibuch der Vereinigten Staaten von Amerika (USP) Lösungen und Reagenzien"
Produkte von "Arzneibuch der Vereinigten Staaten von Amerika (USP) Lösungen und Reagenzien"
Sortieren nach
Amikacin sulfate salt
CAS:Formel:C22H43N5O13·xH2O4S(xFarbe und Form:White to off-white powderMolekulargewicht:585.60 (non-salt)6α-Hydroxybudesonide ((2S,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-Dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormel:C25H34O7Farbe und Form:White Off-White SolidMolekulargewicht:446.23045Prasugrel EP Impurity D-d4 (Prasugrel USP Related Compound D-d4, Prasugrel Metabolite R-95913-d4) (Mixture of Diastereomers)
CAS:Formel:C18H14D4FNO2SFarbe und Form:White To Off-White SolidMolekulargewicht:335.43Plastic Additive 12 (Oleamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormel:C18H35NOFarbe und Form:White PowderMolekulargewicht:281.271863-Methyl Formoterol (N-(2-hydroxy-5-(1-hydroxy-2-((1-(4-methoxy-3-methylphenyl)propan-2-yl)amino)ethyl)phenyl)formamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormel:C20H26N2O4Farbe und Form:SolidMolekulargewicht:358.18926Thiamazole EP Impurity C HCl (Methimazole USP Related Compound C HCl)
CAS:Formel:C5H8N2S·HClFarbe und Form:Pale Orange SolidMolekulargewicht:128.19 36.46Mirtazapine Related Compound C (2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormel:C17H17N3OFarbe und Form:White Off-White Crystalline PowderMolekulargewicht:279.13716Reagecon pH 10.01 at 25°C according to United States Pharmacopoeia (USP)
Reagecon's pH 10.01 at 25°C according to United States Pharmacopoeia (USP) is specified for use in individual United States Pharmacopoeia (USP) Monographs. It is tested by an ISO 17025 Accredited Test Method (A2LA Ref: 6739.03); is NIST traceable and has guaranteed stability throughout its entire shelf life; even after opening the bottle.Farbe und Form:LiquidR-Ofloxacin ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormel:C18H20FN3O4Farbe und Form:Yellow Pale Yellow PowderMolekulargewicht:361.14378Fenofibrate EP Impurity G (Fenofibrate USP Related Compound C)
CAS:Formel:C24H27ClO6Molekulargewicht:446.92Ref: 4Z-T-3411
Ausgelaufenes produktTimolol EP Impurity B (S-Isomer) (Timolol USP Related Compound B (S-Isomer))
CAS:Formel:C13H24N4O3SFarbe und Form:White To Off-White SolidMolekulargewicht:316.43Loperamide Related Compound F (1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine 1-oxide hydrate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormel:C29H33ClN2O3H2OFarbe und Form:White PowderMolekulargewicht:492.21797Verbascoside
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesFormel:C29H36O15Farbe und Form:White Off-White Pale Yellow PowderMolekulargewicht:624.20542Nevirapine Related Compound B (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormel:C12H10N4OFarbe und Form:Yellow Green PowderMolekulargewicht:226.08546[Met(O)27]-Glucagon
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormel:C153H225N43O50SFarbe und Form:White PowderMolekulargewicht:3496.61062Glycopyrrolate Related Compound C (2-Cyclopentyl-2-hydroxy-2-phenylacetic acid)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormel:C13H16O3Farbe und Form:White Off-White PowderMolekulargewicht:220.10994Oxcarbazepine
CAS:Anticonvulsants, hypnotics and sedativesFormel:C15H12N2O2Farbe und Form:Off-White Cream Light Orange PowderMolekulargewicht:252.08988Almotriptan Related Compound B (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFormel:C15H21N3O2S·C4H4O4Farbe und Form:PowderMolekulargewicht:307.13545Iodoquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormel:C9H5I2NOFarbe und Form:Light Brown Yellow PowderMolekulargewicht:396.84606
![Mirtazapine Related Compound C (2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1444241.webp&w=3840&q=75)
